This OTC market w a lot manipulations and sketchy

This OTC market w a lot manipulations and sketchy characters is not the place of a company which has a product portfolio which is as better than the competitors, lower cost base providing very competitive prices and don’t forget it is not discretionary and it will change anytime soon. Anyone who looks at the medical research knows that blood testing is different and it is not replaceable for many. I could never believe the SP and the games being played. I was a buyer at 10, 5, 13 onwards....2018 and beyond we should be in dollars comfortably. The bureaucratic organisations with a lot of overhead and speed of a turtle can not compete with this. It is written everywhere, keep your eyes on the price, we have not seen anything yet. GLTA.